Brennan Kevin M.
Insider CIK 1971303 · XLO SVP, FINANCE AND ACCOUNTING
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| XLO Xilio Therapeutics, Inc. | S Sale | 2026-01-02 | 2026-01-05 | 1,826 | $0.64 | $1.2K | 6,371 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | M Exercise deriv | 2026-01-01 | 2026-01-05 | 5,000 | — | $0 | 10,000 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | M Exercise | 2026-01-01 | 2026-01-05 | 5,000 | — | $0 | 8,197 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2025-12-31 | 2026-01-05 | 95,221 | — | $0 | 95,221 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2025-11-21 | 2025-11-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | D To issuer deriv | 2025-11-21 | 2025-11-25 | 20,000 | — | $0 | 0 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2025-11-21 | 2025-11-25 | 25,000 | — | $0 | 25,000 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | D To issuer deriv | 2025-11-21 | 2025-11-25 | 25,000 | — | $0 | 0 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2025-11-21 | 2025-11-25 | 55,000 | — | $0 | 55,000 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | D To issuer deriv | 2025-11-21 | 2025-11-25 | 55,000 | — | $0 | 0 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2025-11-21 | 2025-11-25 | 131,700 | — | $0 | 131,700 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | S Sale | 2025-01-02 | 2025-01-03 | 1,803 | $0.98 | $1.8K | 3,197 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2025-01-01 | 2025-01-03 | 60,000 | — | $0 | 60,000 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | M Exercise deriv | 2025-01-01 | 2025-01-03 | 5,000 | — | $0 | 15,000 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | M Exercise | 2025-01-01 | 2025-01-03 | 5,000 | — | $0 | 5,000 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2024-10-01 | 2024-10-02 | 26,000 | — | $0 | 26,000 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2024-05-01 | 2024-05-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2024-01-01 | 2024-01-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2023-08-16 | 2023-08-18 | 25,000 | — | $0 | 25,000 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2023-04-01 | 2023-04-03 | 55,000 | — | $0 | 55,000 | SEC↗ |